Search Results - "Madzorera, S."

A38 Diversity analyses of HIV-1 envelope glycoproteins in HIV-infected individuals with and without broadly neutralizing antibodies by Mabvakure, B., Scheepers, C., Nonyane, M., Lambson, B., Madzorera, S., Kitchin, D., Bhiman, J., Wibmer, K., Abdool Karim, S., Williamson, C., Morris, L., Moore, P.L.

Get full text

Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan by Umotoy, Jeffrey, Bagaya, Bernard S., Joyce, Collin, Schiffner, Torben, Menis, Sergey, Saye-Francisco, Karen L., Biddle, Trevor, Mohan, Sanjay, Vollbrecht, Thomas, Kalyuzhniy, Oleksander, Madzorera, Sharon, Kitchin, Dale, Lambson, Bronwen, Nonyane, Molati, Kilembe, William, Poignard, Pascal, Schief, William R., Burton, Dennis R., Murrell, Ben, Moore, Penny L., Briney, Bryan, Sok, Devin, Landais, Elise

“…The VH1-2 restricted VRC01-class of antibodies targeting the HIV envelope CD4 binding site are a major focus of HIV vaccine strategies. However, a detailed…”
Get full text

A1 The role of virus-antibody co-evolution in the development of a V3-glycan-directed HIV-1 broadly neutralizing antibody lineage by Kitchin, D, Bhiman, J, Mvududu, D, Oosthuysen, B, Lambson, B, Madzorera, S, Anthony, C, Abdool Karim, S S, Garrett, N J, Doria-Rose, N A, Mascola, J R, Morris, L, Moore, P L

“…Abstract Broadly neutralizing antibodies (bNAbs) are essential for a preventative HIV-1 vaccine but have not been elicited through vaccination. bNAbs develop…”
Get full text